Table 1 Characteristics of the dengue virus infection cases (n = 532)
Variables | Mean ± standard deviation | Median/Range/Percentages |
|---|---|---|
Age, in years | 35.29 ± 14.70 | 32(15-85) |
Gender | ||
Female | 155 | 29.1% |
Male | 377 | 70.9% |
Length of hospital stay | 3.46 ± 3.45 | 3(1-33 days); 3[2-4] |
Peak creatinine (μmole/litre) | 98.124 ± 83.98 | 79.56(17.68-875.16) |
Peak creatinine in AKI (μmole/litre) | 229.84 ± 174.15 | 149.6(114.92-875.16) |
Admission creatinine (μmole/litre) | 90.16 ± 61.88 | 79.56(17.68-857.48) |
Admission hematocrit (Proportion of 1.0) | 0.4102 ± 0.063 | 0.415(0.199-0.58) |
Peak hematocrit (Proportion of 1.0) | 0.422 ± 0.0563 | 0.424(0.264-0.58) |
Platelets | 38.65 ± 42.14 | 23(2-427) |
Alanine aminotransferase (μkat/L) | 2.73 ± 5.86 | 1.27(0.050-60.55) |
Prothrombin time (Seconds) | 12.82 ± 8.70 | 11.10(3-120) |
aPTT (Seconds) | 36.02 ± 15.12 | 33.35(11.2-120) |
Vasopressin | 5 | 0.9% |
Central nervous system involvement | 11 | 2.1% |
Respiratory failure | 14 | 2.6% |
World Health Organization Classification | ||
Dengue fever | 449 | 84.4% |
Dengue hemorrhagic fever | 76 | 14.3% |
Dengue shock syndrome | 7 | 1.3% |
Length of stay in hospital | ||
≤3 days | 386 | 72.6% |
>3 days | 146 | 27.4% |
Alanine aminotransferase | ||
Normal | 156 | 29.3% |
Mild hepatitis 0.75 - 5.01 μkat/L | 329 | 61.8% |
Severe hepatitis >5.01 μkat/L | 47 | 8.8% |
Prothrombin time (Seconds) | ||
≤15 | 468 | 88% |
>15 | 64 | 12% |
Activated partial thromboplastin time (Seconds) | ||
≤ 35 | 307 | 57.7% |
>35 | 225 | 42.3% |
Platelets (Micro/liter) | ||
<50000 | 406 | 76.3% |
50000-100000 | 93 | 17.5% |
100000-150000 | 23 | 4.3% |
>150000 | 10 | 1.9% |
Number of dengue cases/years | ||
2008 | 76 | 14.3% |
2009 | 148 | 27.8% |
2010 | 308 | 57.9% |